The upregulation of KIAA1429 has been reported in liver cancer [19, 27], colorectal cancer [21, 28], breast cancer [22, 29], lung cancer [17, 30], diffuse large B-cell lymphoma [31], and Ewing sarcoma [32]. Here, VIRMA is linked to breast carcinoma.